| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 08/12/2009 | EP1682121B1 Use of crth2 antagonist compounds in therapy |
| 08/12/2009 | EP1624868B9 "(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)- propyl]phenyl derivatives as beta2 agonists |
| 08/12/2009 | EP1599446B1 An improved process for the preparation of gabalactam |
| 08/12/2009 | EP1567150B1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 08/12/2009 | EP1224170B1 6-position substituted indoline, production and use thereof as a medicament |
| 08/12/2009 | EP1077941B1 Compounds with growth hormone releasing properties |
| 08/12/2009 | CN101506163A Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device |
| 08/12/2009 | CN101506162A Substituted isoindoles as bace inhibitors and their use |
| 08/12/2009 | CN101506161A Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate |
| 08/12/2009 | CN101506160A Positively charged water-soluble prodrugs of aryl- and heteroarylacetic acids with very fast skin penetration rate |
| 08/12/2009 | CN101506159A Compounds having CRTH2 antagonist activity |
| 08/12/2009 | CN101506158A Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 08/12/2009 | CN101503387A Preparation of 3-aryl substituted indole containing ester group at 2 site |
| 08/12/2009 | CN101503386A Method for refining 1-amyl-3-(4-methyl-1-naphthoyl) indole |
| 08/12/2009 | CN101503373A 2-amino-1-(4-nitro phenyl)-1-ethanol metalloid protease inhibitor, and preparation and use thereof |
| 08/12/2009 | CN100526297C Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives |
| 08/12/2009 | CN100526296C Method for purifying and enriching benzene acryloyl 5- hydroxytryptamine derivant in safflower seed |
| 08/12/2009 | CN100526287C C2-phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
| 08/11/2009 | US7572924 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2009 | US7572923 Indirubin derivatives having anticancer property against human cancer cell line |
| 08/11/2009 | US7572824 Methods for minimizing thioamide impurities |
| 08/11/2009 | US7572823 5-Chloro-6-fluoro-1H-indole-7-carboxylic acid [2-(3-trifluoromethoxy-phenyl)-ethyl]-(4-trimethylsilanyl-benzyl)-amide; inhibitors of the cholesteryl ester transfer protein |
| 08/11/2009 | US7572813 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 08/11/2009 | US7572806 PPAR active compounds |
| 08/11/2009 | US7572796 excitatory amino acid antagonists for treating neurodegenerative diseases as cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischaemia, infarction, psychoses; 6-{3-[4-(4-fluorobenzyl)-1-piperidyl]propyl}-1H-indole-3-carbonitrile |
| 08/11/2009 | CA2368688C Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 08/06/2009 | WO2009096555A1 Method for producing compound having deuterated aromatic ring or heterocyclic ring |
| 08/06/2009 | WO2009096526A1 Carboxylic acid compound or salt thereof |
| 08/06/2009 | WO2009095163A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/06/2009 | WO2009094866A1 Dicycloazaalkane derivates, preparation processes and medical uses thereof |
| 08/06/2009 | WO2009063495A3 Substituted indole and its derivatives as cannabinoid modulators |
| 08/06/2009 | WO2009053750A3 Novel crystalline and amorphous forms |
| 08/06/2009 | WO2008103354A3 Modulators of acetyl-coenzyme a carboxylase and methods of use thereof |
| 08/06/2009 | WO2002102301A3 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/06/2009 | US20090198072 monatin is produced from tryptophan by converting tryptophan to indole-3-pyruvate (I3P), reacting I3P with pyruvate to form alpha-keto acid monatin (MP), and then reacting MP to form monatin; high-intensity sweetener |
| 08/06/2009 | US20090197936 Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide |
| 08/06/2009 | US20090197915 Sigma receptor compounds |
| 08/06/2009 | US20090197876 Indolinone derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 08/06/2009 | US20090197198 Photosensitive molecular compound and photoresist composition including the same |
| 08/06/2009 | CA2712854A1 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/06/2009 | CA2712352A1 Dicycloazaalkane derivates, preparation processes and medical uses thereof |
| 08/05/2009 | EP2085382A1 Aromatic amine derivative and organic electroluminescent element using the same |
| 08/05/2009 | EP2085371A1 Fluoranthene compound, organic electroluminescent device using the fluoranthene compound, and organic electroluminescent material-containing solution |
| 08/05/2009 | EP2084131A1 Indole and benzofuran 2-carboxamide derivatives |
| 08/05/2009 | EP2084127A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| 08/05/2009 | EP2084123A1 Anthracene derivative, and light-emitting element, light-emitting device, electronic device using anthracene derivative |
| 08/05/2009 | EP2083818A2 Melatonin derivatives and their use as antioxidants |
| 08/05/2009 | EP2083816A2 Heterocyclic amide compounds useful as kinase inhibitors |
| 08/05/2009 | EP1748783A4 Treatment or prevention of respiratory viral infections with immunomodulator compounds |
| 08/05/2009 | EP1745010B1 Substituted cyclohexyl-1,4-diamine derivatives |
| 08/05/2009 | EP1737821B1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 08/05/2009 | EP1501797B1 3-(substituted amino)-1h-indole-2-carboxylic acid ester and 3-(substituted amino)-benzo[b]thiophene-2-carboxylic acid ester derivatives as interleukin-4 gene expression inhibitors |
| 08/05/2009 | EP1399445B1 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | EP1249233B9 Npyy5 antagonists |
| 08/05/2009 | CN101501018A Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
| 08/05/2009 | CN101500996A (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives |
| 08/05/2009 | CN101500995A 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 08/05/2009 | CN100522991C Peptidomimetic protease inhibitors |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522942C Synthesized intermediate compound of Rosuvastain, preparation method and application |
| 08/05/2009 | CN100522940C Derivatives of alpha-phenylthiocarboxylic and g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPAR alpha activation |
| 08/05/2009 | CN100522937C Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 08/05/2009 | CN100522934C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/05/2009 | CN100522913C High density optical disk and its compound for recording |
| 08/04/2009 | US7569724 Antiproliferative agnets; anticancer agents; skin disorders |
| 08/04/2009 | US7569705 New derivatives for synthesis of hepatitis C virus protease inhibitor boceprevir |
| 08/04/2009 | US7569567 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 08/04/2009 | CA2253977C Process for the preparation of amino alcohols and derivatives thereof |
| 07/30/2009 | WO2009093655A1 Intermediate film for laminated glass and laminated glass |
| 07/30/2009 | WO2009093029A1 Compounds having crth2 antagonist activity |
| 07/30/2009 | WO2009093026A1 Compounds having crth2 antagonist activity |
| 07/30/2009 | WO2009092994A1 Novel salt of tegaserod |
| 07/30/2009 | WO2009092993A1 Novel salt of tegaserod |
| 07/30/2009 | WO2009092581A1 Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same |
| 07/30/2009 | WO2009092580A1 Process for the manufacture of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative |
| 07/30/2009 | WO2009063248A3 Polymorphic forms of tegaserod glutarate |
| 07/30/2009 | WO2009016526A3 Ethers of substituted 5-hydrixy-1h-indol-3-carboxylic acids, a pharmaceutical composition and a method for the production and use thereof |
| 07/30/2009 | WO2008149140A3 Tegaserod oxalate and polymorphic forms |
| 07/30/2009 | WO2008149139A3 Tegaserod fumarate and polymorphic forms |
| 07/30/2009 | WO2008103613A3 Hydroxylamine compounds and methods of their use |
| 07/30/2009 | WO2007146716A3 Polymorphs of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide |
| 07/30/2009 | US20090192319 Methods for treating cognitive /attention deficit disorders using tetrahydroindolone analogues and derivatives |
| 07/30/2009 | US20090192210 Polymorphs of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide |
| 07/30/2009 | US20090192202 4-(2-Cyano-cyclohexyloxy)-2-trifluoromethyl-benzonitrlle; selective androgen receptor modulators; decrease excess sebum secretions; stimulants of hair growth at higher rates of cosmetically acceptable hair growth in patients with alopecia; acne; skin disorders; prostate cancer |
| 07/30/2009 | US20090192195 Compounds Having CRTH2 Antagonist Activity |
| 07/30/2009 | US20090192122 Inflammatory cytokine release inhibitor |
| 07/30/2009 | US20090191183 Substituted indoles |
| 07/30/2009 | US20090189086 Use of aryl-or alkyloxy-substituted phthalocyanines as marking substances for liquids |
| 07/30/2009 | CA2714269A1 Novel salt of tegaserod |
| 07/30/2009 | CA2712388A1 Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same |
| 07/30/2009 | CA2712385A1 Process for the manufacture of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative |
| 07/30/2009 | CA2708523A1 Interlayer film for laminated glass and laminated glass |
| 07/29/2009 | EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 07/29/2009 | EP2081912A1 Heterocyclic bridged biphenyls and their use in oleds |
| 07/29/2009 | EP2081897A1 Isoindol derivatives as ep4 receptor agonists |
| 07/29/2009 | EP2081896A1 Benzoisoindole derivatives and their use as ep4 receptor agonists |
| 07/29/2009 | EP2081895A1 Hydrobenzamide derivatives as inhibitors of hsp90 |
| 07/29/2009 | EP2081894A1 1h-indole-2-carboxylic acid derivatives useful as ppar modulators |
| 07/29/2009 | EP2081893A2 Substituted indoles |